ICD-10 Code C91.31 | Prolymphocytic leukemia of B-cell type, in remission Symptoms, Diagnosis, Billing

Prolymphocytic leukemia of B-cell type, in remission is a rare hematological malignancy characterized by the proliferation of prolymphocytes, a type of B-cell. This condition is clinically significant as it can lead to severe complications if not monitored. The ICD-10 Code C91.31 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage patient care and treatment outcomes.

What is ICD-10 Code C91.31 for Prolymphocytic leukemia of B-cell type, in remission?

ICD-10 Code C91.31 represents Prolymphocytic leukemia of B-cell type, in remission, indicating a state where the disease is not actively progressing. This code is used when documenting patients who have previously been diagnosed with this type of leukemia but are currently in a state of remission. Accurate coding is essential for appropriate clinical documentation and billing, ensuring that healthcare providers receive proper reimbursement for the care provided.

ICD-10 Code C91.31 – Clinical Definition and Explanation of Prolymphocytic leukemia of B-cell type, in remission

Prolymphocytic leukemia of B-cell type is a rare and aggressive form of leukemia characterized by the accumulation of prolymphocytes in the bone marrow and peripheral blood. The condition requires careful monitoring and management, particularly as it can lead to complications such as infections and bleeding disorders. Medical attention is crucial to maintain remission and prevent disease progression.

Key Clinical Features:

• Presence of prolymphocytes in blood and bone marrow.
• Symptoms may include fatigue, lymphadenopathy, and splenomegaly.
• Risk of infections due to immunosuppression.
• Potential for transformation to a more aggressive form of leukemia.

ICD-10 Code C91.31 for Prolymphocytic leukemia of B-cell type, in remission – SOAP Notes & Clinical Use

ICD-10 Code C91.31 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. This code plays a vital role in both acute and chronic care settings, ensuring that healthcare providers can accurately track the patient's condition and response to treatment.

What Does ICD-10 Code C91.31 for Prolymphocytic leukemia of B-cell type, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C91.31 connects subjective patient reports and objective clinical findings to a formal diagnosis of Prolymphocytic leukemia of B-cell type, in remission. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C91.31 – Prolymphocytic leukemia of B-cell type, in remission

Management of Prolymphocytic leukemia of B-cell type, in remission, requires a comprehensive approach to maintain remission and monitor for potential relapse.

Antibiotic Therapy:

• Not typically indicated unless there is an infection; consider prophylactic antibiotics in immunocompromised patients.
• First-line: Ciprofloxacin 500 mg orally twice daily for 7-14 days.
• Alternative: Trimethoprim-sulfamethoxazole 160/800 mg orally daily for 7-14 days.

Supportive Care:

• Regular monitoring of blood counts and clinical status.
• Management of symptoms such as fatigue and splenomegaly.
• Education on infection prevention and signs of relapse.

Infection Control:

• Implement standard precautions to prevent infection.
• Educate patients on hygiene practices.
• Consider isolation during outbreaks of infectious diseases.

How to Document Symptoms of Prolymphocytic leukemia of B-cell type, in remission (ICD-10 C91.31) in SOAP Notes

Subjective:

• Patient reports fatigue and occasional night sweats.
• No recent infections or significant weight loss noted.
• Denies lymphadenopathy or abdominal discomfort.

Objective:

• Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
• CBC shows normal white blood cell count and hemoglobin levels.
• Physical exam reveals no lymphadenopathy or splenomegaly.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Prolymphocytic leukemia of B-cell type, in remission (ICD-10 Code C91.31)

Assessment:

• Prolymphocytic leukemia of B-cell type, in remission (ICD-10 C91.31).
• Patient is stable with no signs of active disease.
• Monitor for potential relapse and manage symptoms.

Plan:

• Continue regular follow-up appointments every 3 months.
• Educate patient on signs of relapse and infection prevention.
• Consider routine blood work to monitor hematological status.

Treatment & Plan Section for ICD-10 Code C91.31 – Prolymphocytic leukemia of B-cell type, in remission

• Monitor blood counts regularly to detect any changes.
• Provide patient education on lifestyle modifications to support health.
• Encourage adherence to follow-up appointments for ongoing assessment.
• Implement strategies for managing fatigue and other symptoms.

Using ICD-10 Code C91.31 for Prolymphocytic leukemia of B-cell type, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of patient history and clinical findings.
• Use C91.31 in conjunction with other relevant codes for comprehensive billing.
• Document treatment plans and patient education efforts clearly.
• Review coding guidelines to ensure compliance with payer requirements.

Related ICD-10 Codes Often Used with Prolymphocytic leukemia of B-cell type, in remission

• C91.30 – Prolymphocytic leukemia of B-cell type, not in remission
• C91.32 – Prolymphocytic leukemia of T-cell type, in remission

ICD-10 Code C91.31 in Medical Billing and Insurance for Prolymphocytic leukemia of B-cell type, in remission

ICD-10 Code C91.31 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the claim.
• Use C91.31 in appropriate settings to ensure accurate reimbursement.
• Include patient education and follow-up care in documentation.

Common CPT Pairings: